Cefdinir Powder, For Suspension
Product Images NDC 68071-5106

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 68071-5106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5106 6)

Label for Cefdinir 250 mg/5 mL oral suspension powder, 60 mL bottle, manufactured by NuCare Pharmaceuticals, Inc. The label includes the NDC 68071-5106-6, dosage form as oral suspension, and a statement that it is Rx only. Additional details include storage instructions to keep at 59-86°F and warnings to keep out of reach of children.*

FDA Label Image

Chemical Structure (Cefdinir Str)

Chemical structure of cefdinir, the active ingredient in the product. The diagram shows the molecular arrangement including rings, double bonds, and functional groups characteristic of cefdinir.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.